• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Let us avoid fluctuations in serum urate in gout.

作者信息

Safar Solaf, Uhlig Till

机构信息

Faculty of Medicine, University of Oslo, Oslo, Norway.

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

出版信息

Clin Rheumatol. 2025 Aug 11. doi: 10.1007/s10067-025-07629-z.

DOI:10.1007/s10067-025-07629-z
PMID:40789974
Abstract
摘要

相似文献

1
Let us avoid fluctuations in serum urate in gout.让我们避免痛风患者血清尿酸水平的波动。
Clin Rheumatol. 2025 Aug 11. doi: 10.1007/s10067-025-07629-z.
2
Evaluation of Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Chronic Refractory Gout in the United States.美国慢性难治性痛风患者的真实世界治疗模式及医疗资源利用情况评估
Adv Ther. 2025 May 8. doi: 10.1007/s12325-025-03189-5.
3
Allopurinol for chronic gout.用于慢性痛风的别嘌醇。
Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD006077. doi: 10.1002/14651858.CD006077.pub3.
4
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review.接受透析的痛风患者中别嘌醇的给药方法、药代动力学及疗效：一项范围综述
J Nephrol. 2025 Mar 25. doi: 10.1007/s40620-025-02269-7.
5
The Gut Microbiome in Hyperuricemia and Gout.高尿酸血症和痛风中的肠道微生物群
Arthritis Rheumatol. 2025 Jan 19. doi: 10.1002/art.43118.
6
Association of urate deposition shown by ultrasound and frequent gout attacks.超声显示尿酸盐沉积与频繁痛风发作的关联。
Z Rheumatol. 2021 Aug;80(6):565-569. doi: 10.1007/s00393-020-00913-0. Epub 2020 Oct 9.
7
Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.用于痛风管理的降尿酸治疗：两项Cochrane系统评价综述
J Rheumatol Suppl. 2014 Sep;92:33-41. doi: 10.3899/jrheum.140460.
8
Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.基于达标维持策略的降尿酸治疗与基于避免症状发作策略的降尿酸治疗在缓解期痛风患者中的比较（GO TEST Finale）：一项多中心实用随机优效性试验的研究方案。
Trials. 2023 Apr 19;24(1):282. doi: 10.1186/s13063-023-07242-y.
9
Empirical dietary index for lower urate concentrations and risk of gout: evidence from cohort studies.降低尿酸浓度和痛风风险的经验性饮食指数：队列研究证据
Am J Clin Nutr. 2025 Jun 30. doi: 10.1016/j.ajcnut.2025.06.021.
10
Change in serum urate level with urate-lowering therapy initiation associates in the immediate term with patient-reported outcomes in people with gout.降尿酸治疗开始时血清尿酸水平的变化与痛风患者的即时患者报告结局相关。
Semin Arthritis Rheum. 2022 Oct;56:152057. doi: 10.1016/j.semarthrit.2022.152057. Epub 2022 Jun 29.

本文引用的文献

1
Gout Flare Burden in the United States: A Multiyear Cross-Sectional Survey Study.美国痛风发作负担：一项多年横断面调查研究。
ACR Open Rheumatol. 2025 Jan;7(1):e11759. doi: 10.1002/acr2.11759. Epub 2024 Nov 5.
2
A genome-wide association analysis reveals new pathogenic pathways in gout.全基因组关联分析揭示了痛风的新致病途径。
Nat Genet. 2024 Nov;56(11):2392-2406. doi: 10.1038/s41588-024-01921-5. Epub 2024 Oct 15.
3
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.
比较起始目标治疗的别嘌醇和非布司他与痛风发作：一项随机多中心试验的事后分析。
Arthritis Rheumatol. 2024 Oct;76(10):1552-1559. doi: 10.1002/art.42927. Epub 2024 Jul 15.
4
The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study.血清尿酸降低对中国男性痛风患者起始降尿酸治疗期间痛风发作风险的影响：一项前瞻性队列研究
J Inflamm Res. 2023 Sep 8;16:3937-3947. doi: 10.2147/JIR.S424820. eCollection 2023.
5
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study.血清尿酸水平的波动和变化与痛风发作：来自 NOR-Gout 研究的结果。
Clin Rheumatol. 2022 Dec;41(12):3817-3823. doi: 10.1007/s10067-022-06416-4. Epub 2022 Nov 1.
6
Change in serum urate level with urate-lowering therapy initiation associates in the immediate term with patient-reported outcomes in people with gout.降尿酸治疗开始时血清尿酸水平的变化与痛风患者的即时患者报告结局相关。
Semin Arthritis Rheum. 2022 Oct;56:152057. doi: 10.1016/j.semarthrit.2022.152057. Epub 2022 Jun 29.
7
Trained immunity and inflammation in rheumatic diseases.训练免疫与风湿性疾病中的炎症反应
Joint Bone Spine. 2022 Jul;89(4):105364. doi: 10.1016/j.jbspin.2022.105364. Epub 2022 Feb 24.
8
Factors Influencing Early Serum Uric Acid Fluctuation After Bariatric Surgery in Patients with Hyperuricemia.影响肥胖症伴高尿酸血症患者减重手术后早期血尿酸波动的因素。
Obes Surg. 2021 Oct;31(10):4356-4362. doi: 10.1007/s11695-021-05579-4. Epub 2021 Jul 26.
9
Pathophysiology of Gout.痛风的病理生理学
Semin Nephrol. 2020 Nov;40(6):550-563. doi: 10.1016/j.semnephrol.2020.12.001.
10
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.培戈洛酶关键试验中慢性难治性痛风的事后分析：血浆尿酸水平波动与急性发作的关系。
Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1085-1092. doi: 10.55563/clinexprheumatol/b7jjnb. Epub 2021 Jan 6.